Ainsworth Sean 4
4 · Ocuphire Pharma, Inc. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
Ainsworth Sean
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-07+20,000→ 20,000 totalExercise: $5.74Exp: 2031-06-07→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.